210 related articles for article (PubMed ID: 22483153)
1. Novel and emerging drugs for acute myeloid leukemia.
Stein EM; Tallman MS
Curr Cancer Drug Targets; 2012 Jun; 12(5):522-30. PubMed ID: 22483153
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
3. Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.
Visani G; Olivieri A; Malagola M; Brunori M; Piccaluga PP; Capelli D; Pomponio G; Martinelli G; Isidori A; Sparaventi G; Leoni P
Leuk Lymphoma; 2006 Jun; 47(6):1091-102. PubMed ID: 16840201
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis targeted therapies in acute myeloid leukemia: an update.
Ball S; Borthakur G
Expert Rev Hematol; 2020 Dec; 13(12):1373-1386. PubMed ID: 33205684
[No Abstract] [Full Text] [Related]
5. Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
Sigal DS; Miller HJ; Schram ED; Saven A
Blood; 2010 Oct; 116(16):2884-96. PubMed ID: 20634380
[TBL] [Abstract][Full Text] [Related]
6. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia.
Tallman MS
Leukemia; 1996 Apr; 10 Suppl 1():S12-5. PubMed ID: 8618462
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
Front Immunol; 2018; 9():977. PubMed ID: 29780393
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.
Short NJ; Konopleva M; Kadia TM; Borthakur G; Ravandi F; DiNardo CD; Daver N
Cancer Discov; 2020 Apr; 10(4):506-525. PubMed ID: 32014868
[TBL] [Abstract][Full Text] [Related]
9. New agents in acute myeloid leukemia and other myeloid disorders.
Ravandi F; Kantarjian H; Giles F; Cortes J
Cancer; 2004 Feb; 100(3):441-54. PubMed ID: 14745859
[TBL] [Abstract][Full Text] [Related]
10. Recent drug approvals for acute myeloid leukemia.
Lai C; Doucette K; Norsworthy K
J Hematol Oncol; 2019 Sep; 12(1):100. PubMed ID: 31533852
[TBL] [Abstract][Full Text] [Related]
11. Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond.
Choi JH; Bogenberger JM; Tibes R
Target Oncol; 2020 Apr; 15(2):147-162. PubMed ID: 32319019
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.
Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F
Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
14. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
Kuendgen A; Germing U
Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
[TBL] [Abstract][Full Text] [Related]
15. [What is recommended in the treatment of acute myeloid leukemia?].
Thol F
Internist (Berl); 2019 Dec; 60(12):1240-1250. PubMed ID: 31690995
[TBL] [Abstract][Full Text] [Related]
16. Haematological cancer: The rule of three in AML induction--is cladribine the answer?
Appelbaum FR
Nat Rev Clin Oncol; 2012 Jun; 9(7):376-7. PubMed ID: 22710339
[No Abstract] [Full Text] [Related]
17. Novel agents in acute myeloid leukemia.
Ungewickell A; Medeiros BC
Int J Hematol; 2012 Aug; 96(2):178-85. PubMed ID: 22907734
[TBL] [Abstract][Full Text] [Related]
18. Vosaroxin : a novel antineoplastic quinolone.
Abbas JA; Stuart RK
Expert Opin Investig Drugs; 2012 Aug; 21(8):1223-33. PubMed ID: 22724917
[TBL] [Abstract][Full Text] [Related]
19. What are the most promising new agents in acute myeloid leukemia?
Sallman DA; Lancet JE
Curr Opin Hematol; 2017 Mar; 24(2):99-107. PubMed ID: 28030373
[TBL] [Abstract][Full Text] [Related]
20. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.
Christian S; Merz C; Evans L; Gradl S; Seidel H; Friberg A; Eheim A; Lejeune P; Brzezinka K; Zimmermann K; Ferrara S; Meyer H; Lesche R; Stoeckigt D; Bauser M; Haegebarth A; Sykes DB; Scadden DT; Losman JA; Janzer A
Leukemia; 2019 Oct; 33(10):2403-2415. PubMed ID: 30940908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
